Accenture insider granted 3,708 Class A shares in equity award

Accenture plc reported an equity grant to one of its senior leaders.

Rhea-AI Filing Summary

Accenture plc reported an equity grant to one of its senior leaders. A company officer serving as Chief Executive Officer-EMEA received 3,708 Class A ordinary shares on 01/01/2026, recorded as an acquisition at a price of $0 per share. This reflects a grant of restricted share units under the Accenture plc Amended and Restated 2010 Share Incentive Plan.

Following this grant, the reporting person beneficially owns 8,123 Class A ordinary shares, held directly. The filing is made on Form 4, which discloses changes in ownership of company equity by insiders.

Insider Trade Summary

Grant/Award: 3,708 shares

Grant/Award 1 txn

Insider Macchi Mauro

Role Chief Executive Officer-EMEA

Type	Security	Shares	Price	Value
Grant/Award	Class A ordinary shares	3,708	$0.00	$0.00

Holdings After Transaction: Class A ordinary shares — 8,123 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of restricted share units awarded under the Accenture plc Amended and Restated 2010 Share Incentive Plan.

FAQ

What insider transaction did Accenture (ACN) report in this Form 4?

The filing reports that a company officer received 3,708 Class A ordinary shares of Accenture plc on 01/01/2026 as part of an equity grant.

Who is the reporting person in this Accenture (ACN) Form 4 filing?

The reporting person is an Accenture plc officer whose relationship is stated as Chief Executive Officer-EMEA.

How many Accenture (ACN) shares does the insider own after the reported transaction?

After the reported grant, the insider beneficially owns 8,123 Class A ordinary shares of Accenture plc, held directly.

What type of equity award was granted in this Accenture (ACN) Form 4?

The transaction represents a grant of restricted share units awarded under the Accenture plc Amended and Restated 2010 Share Incentive Plan.

Was any cash paid for the Accenture (ACN) shares received in this Form 4?

No cash was paid for the grant; the 3,708 Class A ordinary shares were acquired at a stated price of $0 per share.

Is this Accenture (ACN) Form 4 filed for one or multiple reporting persons?

The document indicates that it is a Form filed by One Reporting Person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/05/2026 - 04:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Macchi Mauro

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer-EMEA

3. Date of Earliest Transaction (Month/Day/Year)
01/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	01/01/2026		A(1)		3,708	A	$0	8,123	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted share units awarded under the Accenture plc Amended and Restated 2010 Share Incentive Plan.

Remarks:

	/s/ Danika Haueisen, Attorney-in-Fact for Mauro Macchi	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.